Interested in participating in future research studies? Whether you have had a previous ACL injury or not, you may be able to take part in several research study opportunities. This registry simply collects your contact information and then we will reach out if any study opportunities are available.

We study how the immune system protects against viruses and bacteria without causing excessive harm to organs like the lungs, heart, and kidneys. We need a small amount of blood to study how immune cells ("white blood cells") turn on important proteins when they sense a bacteria or virus nearby.

Have you been diagnosed with Eosinophilic Esophagitis (EoE) and therapies you've tried don't work, or you aren't interested in taking drugs to treat your EoE? Are you willing to modify your diet to exclude certain foods for 8 weeks? If so, then you may be eligible to participate in a study to see if an individualized diet elimination therapy works to treat EoE.

Have you been listed for kidney transplant at UNC? If so, you may be able to take part in a research study to help us learn how the process of waiting for a kidney transplant impacts you.

Have you been diagnosed with locally advanced head and neck squamous cell carcinoma? If so, you may be able to participate in a research study to evaluate whether pembrolizumab and olaparib given before and after chemoradiotherapy can improve 1-year progression free survival.

Have you had ACL reconstruction? You may be able to participate in a research study examining how brain function might change after surgery. Compensation provided.

Have you or a family member been diagnosed with Parkinson's Disease? Would you be interested in helping researchers learn more about Parkinson's by giving a blood or saliva sample? If so, you may be eligible to participate in a research study that will utilize genetic testing to provide you more information about the possible roles of your genes in your diagnosis.

Do you have a newly diagnosed endometrial cancer? if so, you may be eligible to participate in a research study looking at the role the uterine and gut microbiomes play in endometrial cancer development and treatment.

Have you been diagnosed with multiple myeloma that has returned and needed to be treated again? If so, you may be able to take part in a research study looking at the safety of giving a new drug called REGN5458 (Linvoseltamab) to patients with relapsed/refractory multiple myeloma.

People with kidney disease that have the APOL1 risk variant are at a greater risk for developing protein in their urine and chronic kidney disease. This research study is being done to determine if the investigational drug, VX-147 can slow or stop the worsening of kidney function as well as target the underlying cause of kidney disease.